Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
77
Views
2
CrossRef citations to date
0
Altmetric
Commentary

Axillary management still needed for patients with sentinel node micrometastases

Bin-Bin Cong1 School of Medicine and Life Sciences, University of Jinan and Shandong Academy of Medical Sciences, Jinan, Shandong, China;2 Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected];3 Department of Radiotherapy, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected];4 Shandong Academy of Medical Sciences, Jinan, Shandong, China, [email protected], [email protected]
,
Jin-Ming Yu3 Department of Radiotherapy, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected];4 Shandong Academy of Medical Sciences, Jinan, Shandong, China, [email protected], [email protected]Correspondence[email protected] [email protected]
&
Yong-Sheng Wang2 Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected];4 Shandong Academy of Medical Sciences, Jinan, Shandong, China, [email protected], [email protected]Correspondence[email protected] [email protected]
Pages 2097-2100 | Published online: 08 Mar 2019

References

  • GiulianoAEBallmanKVMcCallLEffect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trialJAMA20173181091892628898379
  • GalimbertiVColeBFVialeGAxillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trialLancet Oncol201819101385139330196031
  • GradisharWJAndersonBOBalassanianRNCCN guidelines insights: breast cancer, version 1.2017J Natl Compr Canc Netw201715443345128404755
  • MorrowMManagement of the node-positive axilla in breast cancer in 2017: selecting the right optionJAMA Oncol20184225025129242929
  • JagsiRChadhaMMoniJRadiation field design in the ACOSOG Z0011 (Alliance) trialJ Clin Oncol201432323600360625135994
  • ReznikJCicchettiMGDegaspeBFitzgeraldTJAnalysis of axillary coverage during tangential radiation therapy to the breastInt J Radiat Oncol Biol Phys200561116316815629607
  • GalimbertiVColeBFZurridaSAxillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trialLancet Oncol201314429730523491275
  • SoláMAlberroJAFraileMComplete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000Ann Surg Oncol201320112012722956062
  • SávoltÁPéleyGPolgárCEight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla – surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trialEur J Surg Oncol201743467267928139362
  • RutgersERadiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10-year results of the EORTC AMA-ROS trialProceedings from the 2018 San Antonio Breast Cancer SymposiumDecember 4–8San Antonio, Texas
  • PoortmansPPostmastectomy radiation in breast cancer with one to three involved lymph nodes: ending the debateLancet201438399352104210624656686
  • GoyalADodwellDPOSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastasesClin Oncol20152712692695
  • HouvenaeghelGResbeutMBoherJMGanglion sentinelle envahi: fautil faire le curage ou pas? Essai randomisé SERC [Sentinel node invasion: is it necessary to perform axillary lymph node dissection? Randomized trial SERC]Bull Canc2014101358363 French
  • van RoozendaalLMde WiltJHvan DalenTThe value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)BMC Canc201515610

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.